Login / Signup

Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies.

Christopher T RitchlinPhillip J MeaseWolf-Henning BoehnckeJohn TesserElena SchiopuSoumya D ChakravartyAlexa P KollmeierXie L XuMay ShawiYusang JiangShihong ShengYanli WangStephen XuJoseph F MerolaIain B McInnesAtul Deodhar
Published in: RMD open (2022)
NCT03162796, NCT03158285.
Keyphrases
  • phase iii
  • placebo controlled
  • double blind
  • phase ii
  • clinical trial
  • study protocol
  • open label
  • phase ii study
  • randomized controlled trial
  • case control
  • squamous cell carcinoma